Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Serinol. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102731324B reveals a safer, cost-effective serinol synthesis route using normal-pressure hydrazine reduction, ideal for iopamidol manufacturing.
Patent CN102731324A reveals a safe, normal-pressure catalytic reduction method for serinol, offering significant cost reduction in pharmaceutical intermediates manufacturing.
Patent CN1122658C details advanced isoserinol purification achieving ultra-low impurities for contrast agents. Offers supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Novel homogeneous catalytic process for Serinol production reduces steps and waste, offering cost reduction in API intermediate manufacturing and reliable supply chain continuity.